1. Brimonidine gel: new prescribing advice from MHRA

   News item 19 November 2016 Pages: 1 - 1

2. Lenalidomide leads to viral reactivation of HBV, HZV

   Correspondence 19 November 2016 Pages: 2 - 2

3. Risk of PAH with IFN-β products, says Health Canada

   News item 19 November 2016 Pages: 3 - 3

4. Risk of suicidal behaviour/ideation, depression with Otezla

   Correspondence 19 November 2016 Pages: 4 - 4

5. Celecoxib cardiovascular safety noninferior to naproxen, ibuprofen

   Clinical study 19 November 2016 Pages: 5 - 5

6. Golimumab: 5-year pooled clinical trial safety data

   Clinical study 19 November 2016 Pages: 6 - 6

7. Ipilimumab and nivolumab: fatal myocarditis

   Clinical study 19 November 2016 Pages: 7 - 7

8. Prenatal antidepressants increase morbidity and hospitalisation

   Clinical study 19 November 2016 Pages: 8 - 8

9. Risk of gestational diabetes with elevated iron stores

   Clinical study 19 November 2016 Pages: 9 - 9

10. Statins: can metabolic markers predict diabetogenic effect?

    Clinical study 19 November 2016 Pages: 10 - 10

11. Structural birth defects following Tdap vaccination

    Clinical study 19 November 2016 Pages: 11 - 11

12. 10-hydroxycamptothecin/epirubicin/fluorouracil

    Case report 19 November 2016 Pages: 12 - 12

13. Abciximab

    Case report 19 November 2016 Pages: 13 - 13

14. Aciclovir

    Case report 19 November 2016 Pages: 14 - 14

15. Acitretin

    Case report 19 November 2016 Pages: 15 - 15

16. Adalimumab

    Case report 19 November 2016 Pages: 16 - 16

17. Adalimumab

    Case report 19 November 2016 Pages: 17 - 17

18. Adalimumab

    Case report 19 November 2016 Pages: 18 - 18

19. Adalimumab

    Case report 19 November 2016 Pages: 19 - 19

20. Adalimumab

    Case report 19 November 2016 Pages: 20 - 20

21. Adalimumab

    Case report 19 November 2016 Pages: 21 - 21

22. Adalimumab

    Case report 19 November 2016 Pages: 22 - 22

23. Adalimumab

    Case report 19 November 2016 Pages: 23 - 23

24. Adalimumab/azathioprine

    Case report 19 November 2016 Pages: 24 - 24

25. Adalimumab/etanercept

    Case report 19 November 2016 Pages: 25 - 25

26. Adalimumab/prednisone

    Case report 19 November 2016 Pages: 26 - 26

27. Alendronic acid

    Case report 19 November 2016 Pages: 27 - 27

28. Alendronic acid

    Case report 19 November 2016 Pages: 28 - 28

29. Alendronic acid/prednisolone

    Case report 19 November 2016 Pages: 29 - 29

30. Allopurinol

    Case report 19 November 2016 Pages: 30 - 30

31. Allopurinol

    Case report 19 November 2016 Pages: 31 - 31

32. Allopurinol/mercaptopurine

    Case report 19 November 2016 Pages: 32 - 32

33. Amantadine

    Case report 19 November 2016 Pages: 33 - 33

34. Amfetamine/dexamfetamine abuse

    Case report 19 November 2016 Pages: 34 - 34

35. Amfetamine/dexamfetamine/lisdexamfetamine

    Case report 19 November 2016 Pages: 35 - 35

36. Amoxicillin/clarithromycin

    Case report 19 November 2016 Pages: 36 - 36

37. Amoxicillin/clavulanic-acid/omeprazole

    Case report 19 November 2016 Pages: 37 - 37

38. Angiotensin receptor blocker/olmesartan medoxomil

    Case report 19 November 2016 Pages: 38 - 38

39. Antiepileptics

    Case report 19 November 2016 Pages: 39 - 39

40. Antineoplastics

    Case report 19 November 2016 Pages: 40 - 40

41. Antineoplastics

    Case report 19 November 2016 Pages: 41 - 41

42. Antineoplastics

    Case report 19 November 2016 Pages: 42 - 42

43. Antineoplastics

    Case report 19 November 2016 Pages: 43 - 43

44. Antiretrovirals

    Case report 19 November 2016 Pages: 44 - 44

45. Antiretrovirals

    Case report 19 November 2016 Pages: 45 - 45

46. Antiretrovirals/simvastatin interaction

    Case report 19 November 2016 Pages: 46 - 46

47. Antiulcers/furosemide/insulin glargine

    Case report 19 November 2016 Pages: 47 - 47

48. Apixaban/aspirin/clopidogrel

    Case report 19 November 2016 Pages: 48 - 48

49. Aspirin

    Case report 19 November 2016 Pages: 49 - 49

50. Aspirin

    Case report 19 November 2016 Pages: 50 - 50